FDA orders more disclosure of attention-deficit drugs
Eli Lilly and Co. and other companies that make drugs for attention deficit hyperactivity disorder have been ordered by the U.S. Food and Drug Administration to develop handouts to give to patients warning of side affects. Some patients with heart problems have died suddenly or sustained strokes and heart attacks after taking the drugs, the […]